gmp violations
Novo Nordiskās semaglutide facility in North Carolina faces FDA scrutiny over quality issues
Anika Sharma
Novo Nordisk’s shares faced a decline following reports that the FDA had raised concerns about manufacturing issues at the company’s ...
